🇺🇸 FDA
Pipeline program

Levofloxacin

LVX-AIS

Unknown small_molecule active

Quick answer

Levofloxacin for Acute Ischemic Stroke is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 3 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Acute Ischemic Stroke
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials